BC Extra | Dec 9, 2014
Financial News

Nanomedicine play Midatech raises L32 million in IPO

Midatech Pharma plc (LSE:MTPH) raised L32 million ($49.8 million) through the sale of 12 million shares at 267p in an IPO on the London Stock Exchange's AIM. The price valued Midatech at L74.2 million ($115.4...
BC Week In Review | Sep 22, 2014
Company News

Q Chip ophthalmic news

Q Chip spun out OpsiRx Pharmaceuticals Ltd. to develop products to treat serious ocular diseases, including uveitis, glaucoma and age-related macular degeneration (AMD). The preclinical products are designed to provide sustained drug release over three...
BC Week In Review | Dec 17, 2012
Company News

Q Chip management update

Q Chip Ltd. , Cardiff, U.K.   Business: Microfluidics, Drug delivery   Hired: Tim Sparey as CEO and a director, formerly head of business development at Proximagen Group plc , which Upsher-Smith Laboratories Inc. acquired  ...
BC Week In Review | Dec 17, 2012
Financial News

Q Chip completes venture financing

Q Chip Ltd. , Cardiff, U.K.   Business: Microfluidics, Drug delivery   Date completed: 12/11/12   Type: Venture financing   Raised: £2 million ($3.2 million)   Investors: Disruptive Capital Finance; Finance Wales; Limburg Ventures; angel investors...
BC Week In Review | Dec 5, 2011
Company News

Q Chip deal

Q Chip partnered with an undisclosed pharmaceutical company to develop a sustained release depot of an undisclosed therapeutic peptide using Q Chip's encapsulation technology. The partner will fund all preclinical and clinical development. Q Chip,...
BC Week In Review | May 30, 2011
Financial News

Q Chip financial update

Q Chip raised £1.6 million ($2.6 million) in a second close of a Series C round, bringing the total raised in the round to £3.6 ($5.7 million). The close was led by Limburg Ventures and...
BC Week In Review | Sep 20, 2010
Financial News

Q Chip completes venture financing

Q Chip Ltd. , Cardiff, U.K.   Business: Microfluidics, Drug delivery   Date completed: 9/13/10   Type: Venture financing   Raised: £2 million ($3.1 million)   Investors: Curzon Park Capitol; Finance Wales  ...
BC Week In Review | May 10, 2010
Company News

Artes Biotechnology, Q Chip deal

The companies partnered to develop monthly sustained-release formulations of interferon alpha 2a to treat HCV and HBV. The partners will evaluate Q Chip's Q-Sphera peptide and protein delivery technology with interferon alpha 2a produced using...
Items per page:
1 - 8 of 8
BC Extra | Dec 9, 2014
Financial News

Nanomedicine play Midatech raises L32 million in IPO

Midatech Pharma plc (LSE:MTPH) raised L32 million ($49.8 million) through the sale of 12 million shares at 267p in an IPO on the London Stock Exchange's AIM. The price valued Midatech at L74.2 million ($115.4...
BC Week In Review | Sep 22, 2014
Company News

Q Chip ophthalmic news

Q Chip spun out OpsiRx Pharmaceuticals Ltd. to develop products to treat serious ocular diseases, including uveitis, glaucoma and age-related macular degeneration (AMD). The preclinical products are designed to provide sustained drug release over three...
BC Week In Review | Dec 17, 2012
Company News

Q Chip management update

Q Chip Ltd. , Cardiff, U.K.   Business: Microfluidics, Drug delivery   Hired: Tim Sparey as CEO and a director, formerly head of business development at Proximagen Group plc , which Upsher-Smith Laboratories Inc. acquired  ...
BC Week In Review | Dec 17, 2012
Financial News

Q Chip completes venture financing

Q Chip Ltd. , Cardiff, U.K.   Business: Microfluidics, Drug delivery   Date completed: 12/11/12   Type: Venture financing   Raised: £2 million ($3.2 million)   Investors: Disruptive Capital Finance; Finance Wales; Limburg Ventures; angel investors...
BC Week In Review | Dec 5, 2011
Company News

Q Chip deal

Q Chip partnered with an undisclosed pharmaceutical company to develop a sustained release depot of an undisclosed therapeutic peptide using Q Chip's encapsulation technology. The partner will fund all preclinical and clinical development. Q Chip,...
BC Week In Review | May 30, 2011
Financial News

Q Chip financial update

Q Chip raised £1.6 million ($2.6 million) in a second close of a Series C round, bringing the total raised in the round to £3.6 ($5.7 million). The close was led by Limburg Ventures and...
BC Week In Review | Sep 20, 2010
Financial News

Q Chip completes venture financing

Q Chip Ltd. , Cardiff, U.K.   Business: Microfluidics, Drug delivery   Date completed: 9/13/10   Type: Venture financing   Raised: £2 million ($3.1 million)   Investors: Curzon Park Capitol; Finance Wales  ...
BC Week In Review | May 10, 2010
Company News

Artes Biotechnology, Q Chip deal

The companies partnered to develop monthly sustained-release formulations of interferon alpha 2a to treat HCV and HBV. The partners will evaluate Q Chip's Q-Sphera peptide and protein delivery technology with interferon alpha 2a produced using...
Items per page:
1 - 8 of 8